Functional activation was detected in all but six completed scans (three scans of patients with unilateral and three with bilateral disease). The primary locus of activation was generally located in the anterior portion of the visual cortex (
Fig. 1), corresponding to the peripheral visual field. The sign of the BOLD signal change during visual stimulation was predominately negative in 87 of 100 examinations (
Fig. 2). As exemplified in
Figure 1, the clusters of positive signal change were generally small and scattered in the striate and extrastriate visual areas. The median value of the maximum
t-statistic was greater (GEE,
P < 0.001) for the negative signal changes (8.5) than for the positive signal changes (4.5), and the number of activated voxels (volume) with a negative signal (1196 voxels) was 13.4 times greater (
P < 0.001) than the number with a positive signal (89 voxels). The activated volume was associated with the peak signal change for both positive (GEE,
P < 0.001) and negative (GEE,
P < 0.001) changes during visual stimulation. The maximum
t-statistic was associated with age (
Fig. 3) for positive signal changes (GEE,
P = 0.03), but not for negative responses. Visual inspection of
Figure 3 shows that there was a similar increasing trend in the magnitude of both positive and negative signal changes with age for the low
t-statistic values at the threshold of detection. There was no association between the volume of visual cortex activated and age at examination. Subsequent analysis was based on the regions with negative BOLD signal.
The volume of activation was greater in patients with unilateral disease than in those with bilateral disease (1876 vs. 751 voxels/scan; GEE, P = 0.04). There was no difference between activation detected before enucleation and that detected afterward in patients with unilateral or bilateral disease or in all patients analyzed together. This comparison included all scans obtained before and after enucleation within each group. In addition, we analyzed scans from a group of nine patients with unilateral disease by focusing on the volume of activation in the last scan before enucleation and comparing the data with those from the first scan after enucleation in each patient. Again, there was no detectable effect of enucleation (data not shown).
We then evaluated the difference in the volumes of activation between hemispheres in patients with unilateral disease who underwent enucleation. Activation was significantly greater in the hemisphere contralateral to the remaining eye (1221 vs. 657 voxels/scan; GEE,
P < 0.002). To demonstrate that there was no left or right hemispheric bias in this finding, we compared left and right hemisphere activation in this same group of patients and found no significant difference (
P = 0.113). In patients with bilateral disease who had not undergone enucleation, the volume of activation in those with macular involvement in one eye was significantly greater than that in patients with macular involvement in both eyes (1672 vs. 426 voxels/scan; GEE,
P = 0.003). Finally, the volume of activation in patients with bilateral disease was greater in those with retinal detachment in one eye than in those with retinal detachment in both eyes (990 vs. 199 voxels/scan; GEE,
P = 0.03). Images of retinoblastoma involving the macula, retinoblastoma involving the retinal periphery, retinoblastoma with retinal detachment, and normal retina, are shown in
Figure 4.